On March 6, 2025, British Columbia became the second province to announce the signing of a pharmacare agreement with Canada’s federal government. Manitoba was the first province to do so, on February 27, 2025 (our report here).
March 2025
Agile licensing, risk, biologics, and more: Wide-ranging amendments to Canada’s drug and medical device regulations



By Sarah Pennington, Paul Jorgensen & Kristin Wall on
Canada has made wide-ranging amendments to the Food and Drug Regulations (FDR) and the Medical Devices Regulations (MDR). The amendments are intended to deliver on Health Canada’s modernization commitments, codify long-standing policies and practices, and implement…